New RNAi treatment targets eye inflammation
Tuesday, February 14, 2017 - 11:32
in Health & Medicine
Scientists have developed a new RNA interference (RNAi) therapeutic agent that safely blocked ocular inflammation in mice, potentially making it a new treatment for human uveitis and diabetic retinopathy.